Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Brazil
  4. Bolsa de Valores de Sao Paulo
  5. JBS S.A.
  6. News
  7. Summary
    JBSS3   BRJBSSACNOR8

JBS S.A.

(JBSS3)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

JBS Is Entering the Cultivated Protein Market with the Acquisition of Biotech Foods and the Construction of A Plant in Europe

11/18/2021 | 09:00am EST

JBS entered into an agreement to acquire control of Spanish company BioTech Foods. The deal signals the company's entry into the cultivated protein market, which consists of producing food from animal cells and includes investment in building a new plant in Spain to scale up production. Along with the acquisition, JBS is also announcing the setting up of Brazil's first cultivated protein research & development (R&D) center. In all, JBS will channel US$ 100 million to the two projects. Under the terms of the deal, JBS becomes the majority shareholder of BioTech Foods. The deal enables both companies to pool their strengths and accelerate the development of the cultivated protein market. JBS will have access to BioTech Foods technology and protein production capability while providing the industrial processing capacity, marketing structure and sales channels to bring the new product to market. When commercial operations begin, the cultivated protein will reach consumers in the form of prepared foods, such as hamburgers, steaks, sausage meats, and meatballs, among others, with the same quality, safety, taste and texture as traditional protein. The technology has the potential not only for the production of beef protein, but also chicken, pork and fish.


ę S&P Capital IQ 2021
All news about JBS S.A.
01/19ANALYSIS-HIGH U.S. MEAT PRICES : packer profiteering or capacity crunch?
RE
01/14LIVESTOCK-CME hog futures rebound, though U.S. slaughtering remains weak
RE
01/14Nearly 90% of big US meat plants had COVID-19 cases in pandemic's first year - data
RE
01/13Brazil meatpacker Minerva mulls switch to Nasdaq listing -source
RE
01/13Brazil meatpacker Minerva mulling change of domicile
RE
01/03Biden unveils plan to boost competition in U.S. meat industry
RE
2021JBS S.A.(BOVESPA : JBSS3) dropped from Brazil Valor BM&FBOVESPA Index
CI
2021WALL STREET STOCK EXCHANGE : Brazilian companies hear the siren's call of U.S. stock excha..
RE
2021European supermarkets stop selling Brazil beef over deforestation links
RE
2021Brazil's Minerva Shares Jump 8.1% on China Reopening; JBS, BRF Also Rise
DJ
More news
Analyst Recommendations on JBS S.A.
More recommendations
Financials
Sales 2021 343 B 62 500 M 62 500 M
Net income 2021 15 789 M 2 875 M 2 875 M
Net Debt 2021 51 546 M 9 385 M 9 385 M
P/E ratio 2021 4,91x
Yield 2021 5,29%
Capitalization 83 654 M 15 203 M 15 232 M
EV / Sales 2021 0,39x
EV / Sales 2022 0,38x
Nbr of Employees 250 000
Free-Float 34,5%
Chart JBS S.A.
Duration : Period :
JBS S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JBS S.A.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 13
Last Close Price 35,83 BRL
Average target price 48,52 BRL
Spread / Average Target 35,4%
EPS Revisions
Managers and Directors
Gilberto Tomazoni Chief Executive & Operating Officer
Guilherme Perboyre Cavalcanti Chief Financial & Investor Relations Officer
Jeremiah Alphonsus O'Callaghan Chairman
Eliseo Santiago Perez Fernandez Director-Administration & Control
Cledorvino Belini Independent Director
Sector and Competitors